Corvus Pharmaceuticals (CRVS) Net Cash Flow Growth (3y) (2018 - 2026)
Corvus Pharmaceuticals (CRVS) Net Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.47% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - | 129.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.80% |
| Dec 31, 2025 | 29.06% |
| Sep 30, 2025 | -44.87% |
| Jun 30, 2025 | 73.79% |
| Mar 31, 2025 | 51.10% |
| Dec 31, 2024 | 35.00% |
| Sep 30, 2024 | -40.26% |
| Jun 30, 2024 | -54.17% |
| Mar 31, 2024 | -29.67% |
| Dec 31, 2023 | -4.70% |
| Sep 30, 2023 | 76.31% |
| Jun 30, 2023 | 10.84% |
| Mar 31, 2023 | -29.88% |
| Dec 31, 2022 | -42.94% |
| Sep 30, 2022 | 43.10% |
| Jun 30, 2022 | 30.26% |
| Mar 31, 2022 | -425.90% |
| Dec 31, 2021 | -78.51% |
| Sep 30, 2021 | 1.81% |
| Jun 30, 2021 | 29.77% |